Advanced Therapies Europe 2020

29TH - 30TH SEPTEMBER 2020


About Phacilitate

About Phacilitate

Who are Phacilitate?

Our belief in the power of partnerships is the underlying value that influences everything we do

As the saying goes, the whole is greater than the sum of its parts, and this is never more true than in the cell and gene therapy space. 

Team Phacilitate

In a disruptive, cutting-edge industry likes ours no single person or entity has all of the answers. By fostering the community and bringing together a diverse range of expertise from across the advanced therapies ecosystem, Phacilitate is creating a network of partnerships and relationships that bring us closer to achieving the ultimate goal of improving patient care and developing commercially viable curative treatments.

The pillars of our philosophy come to life in our award-winning events, which focus on the science and the business of advanced therapies.

In an ever-evolving landscape of clinical trials, regulations and new technology, we recognise it can be difficult to keep up to date with it all. Which is why in our 16-year history, as the industry grows at an unprecedented rate, so have the scale and range of Phacilitate's events, which explore new formats for information sharing and showcasing innovative technologies among key opinion leaders and beyond. 

Our conferences create a platform in which scientists, investors, solution providers, doctors and patient advocates alike can all come together to discuss the latest developments in cell and gene therapy. 

After all, bringing people together is what we are all about.                 Meet the team


What's taking place this year? Click here to download our 2019/2020 events calendar.

advanced therapies event calendar 2019/20 phacilitate


Find out more about Phacilitate Leaders Europe

  • Real thinking forward combining experts in the field from manufacturing, regulatory and value vision” – “great network with strong experience and sharing risks & opportunities
    Jean-Philippe Combal
    GenSight Biologics
  • The conference consistently proves to be a great forum for networking with industry leaders in the development of cellular and gene therapies as well as vendors for important technologies and services.
    Michael Covington
    Juno Therapeutics, Inc
  • It was a very interesting event as all participants, including speakers were ready to exchange, even on the most challenging subjects such as reimbursement, GMP guidance
    Bertrand Alexandre
  • Phacilitate EU delivered it's promise and more, the topics discussed were highly relevant, with very good and professional speakers and panelists. You will see me next year in Berlin.
    Dr Ohad Karnieli
    Karnieli Ltd